Gilman Steven C
SEC-identified person · CIK 1379970 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Scynexis INC SCYX | Director | filed 2015 - 2025 |
| Akebia Therapeutics, Inc. AKBA | Director | filed 2018 - 2025 |
| Vericel Corp astm | Director | filed 2015 - 2024 |
| Contrafect Corp CRFX | Director · Interim CEO | filed 2015 - 2022 |
| Momenta Pharmaceuticals INC MNTA | Director | filed 2016 - 2020 |
| Keryx Biopharmaceuticals INC KERX | Director | filed 2016 - 2018 |
| Cubist Pharmaceuticals INC cbst | Senior Vice President | filed 2008 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.